Stroke Reports
Friday, January 10th, 2014
J NeuroIntervent Surg: January 2, 2014 While intravenous administration of tissue plasminogen activator (tPA) remains the only FDA-approved treatment modality for acute ischemic stroke, many patients do not meet the criteria for intravenous tPA and are offered intra-arterial therapy. Rapid advances in devices and approaches have marked the evolution of thrombectomy over the past decade from […]
Stroke Reports
Friday, January 10th, 2014
Neurology: December 20, 2013 Objectives: To examine 18-year trends in short-term and long-term stroke mortality and the prognostic influence of comorbidity. Methods: We conducted a nationwide population-based cohort study. Using the Danish National Registry of Patients, covering all Danish hospitals, we identified all 219,354 patients with a first-time hospitalization for stroke during 1994–2011. We computed standardized 30-day, 1-year, […]
Stroke Reports
Friday, January 10th, 2014
Wiley: DEC 19, 2013 Background and Purpose The study aims to compare lipid profiles among ischemic stroke patients in a predominantly Caribbean-Hispanic population in Miami and a Mestizo Hispanic population in Mexico City. Methods We analyzed ischemic stroke Hispanic patients with complete baseline fasting lipid profile enrolled contemporaneously in the prospective registries of two tertiary care […]
Stroke Reports
Friday, January 10th, 2014
American Heart Association: December 18, 2013 Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease Control and Prevention, the National Institutes of Health, and other government agencies, brings together the most up-to-date statistics on heart disease, stroke, other vascular diseases, and their risk factors and presents them in its Heart Disease […]
Stroke Reports
Friday, January 10th, 2014
Eur Heart J (2013): December 18, 2013 Aims An increased risk of stroke was observed in two atrial fibrillation (AF) trials of oral factor Xa inhibitors, when patients were transitioned to open label warfarin at the end of the study. The objective of this study is to determine whether initiation of warfarin is associated with an increased risk […]
